apomorphine
Selected indexed studies
- Apomorphine-subcutaneous--Bertek/Britannia. (Drugs R D, 2004) [PMID:15230626]
- [Apomorphine and frontal dysfunction in Parkinson's disease]. (Rev Neurol, 2022) [PMID:35635363]
- Sublingual apomorphine in treatment of Parkinson's disease: a review. (Int J Neurosci, 2024) [PMID:35986574]
_Worker-drafted node — pending editorial review._
Connections
apomorphine is a side effect of
Sources
- Apomorphine-subcutaneous--Bertek/Britannia. (2004) pubmed
- [Apomorphine and frontal dysfunction in Parkinson's disease]. (2022) pubmed
- Sublingual apomorphine in treatment of Parkinson's disease: a review. (2024) pubmed
- An evaluation of subcutaneous apomorphine for the treatment of Parkinson's disease. (2020) pubmed
- [Apomorphine]. (1995) pubmed
- Apomorphine - pharmacological properties and clinical trials in Parkinson's disease. (2016) pubmed
- Apomorphine in dopaminergic therapy. (2006) pubmed
- [Apomorphine in the treatment of Parkinson's Disease]. (2005) pubmed
- Apomorphine induces mitochondrial-dysfunction-dependent apoptosis in choriocarcinoma. (2020) pubmed
- Apomorphine and levodopa in Parkinson's disease: Two revolutionary drugs from the 1950's. (2016) pubmed